The U.S. Food and Drug Administration has approved the marketing of a new tool to that can test a person’s blood to diagnose ...

The test is for those aged 55 and older who are already exhibiting signs and symptoms of Alzheimer's disease. “In the long ...

A simple blood draw has now become a powerful tool in the early fight against Alzheimer’s. The FDA has approved the first blood test to help detect signs of ...

Multiple myeloma is considered incurable, but a third of patients in a clinical trial have lived without detectable cancer for years, after facing certain death ...

About 90% of people who have the disease are Black or of African descent, the institute says on its website. However, only ...

New blood tests can detect cancer recurrence earlier than traditional scans, potentially giving doctors and patients crucial ...

ASCO Data Shows New Therapy Keeps Myeloma Patients in Remission for 5+ Years. Here's what you need to know about the ...

In a new report published in JAMA Cardiology, health policy experts at the Richard A. and Susan F. Smith Center for Outcomes ...

At 38, author Jonathan Gluck was diagnosed with blood cancer and given less than three years to live. Twenty-two years later, ...

Here is a recap of every FDA approval announced by the regulatory agency in the month of May, spanning various cancer types.

The Lumipulse test has specifically been approved to help diagnose the disease in the clinical setting. Dr. Amanada Smith said that makes it the first and only test with that advantage.